250 related articles for article (PubMed ID: 15328170)
1. Isolated tumor cells in bone marrow three years after diagnosis in disease-free breast cancer patients predict unfavorable clinical outcome.
Wiedswang G; Borgen E; Kåresen R; Qvist H; Janbu J; Kvalheim G; Nesland JM; Naume B
Clin Cancer Res; 2004 Aug; 10(16):5342-8. PubMed ID: 15328170
[TBL] [Abstract][Full Text] [Related]
2. Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer.
Wiedswang G; Borgen E; Kåresen R; Kvalheim G; Nesland JM; Qvist H; Schlichting E; Sauer T; Janbu J; Harbitz T; Naume B
J Clin Oncol; 2003 Sep; 21(18):3469-78. PubMed ID: 12972522
[TBL] [Abstract][Full Text] [Related]
3. The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence.
Janni W; Rack B; Schindlbeck C; Strobl B; Rjosk D; Braun S; Sommer H; Pantel K; Gerber B; Friese K
Cancer; 2005 Mar; 103(5):884-91. PubMed ID: 15666325
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis between the HER2 status in primary breast cancer tissue and the detection of isolated tumor cells in the bone marrow.
Schindlbeck C; Janni W; Shabani N; Rack B; Gerber B; Schmitt M; Harbeck N; Sommer H; Braun S; Friese K
Breast Cancer Res Treat; 2004 Sep; 87(1):65-74. PubMed ID: 15377852
[TBL] [Abstract][Full Text] [Related]
5. The prognostic impact of occult nodal metastasis in early breast carcinoma.
Park D; Kåresen R; Naume B; Synnestvedt M; Beraki E; Sauer T
Breast Cancer Res Treat; 2009 Nov; 118(1):57-66. PubMed ID: 19219629
[TBL] [Abstract][Full Text] [Related]
6. Positive bone marrow biopsy is associated with a decreased disease-free survival in patients with operable breast cancer.
Fortunato L; Mascaro A; Baldi A; Farina M; Cortese G; Ventrone MA; Amini M; Vitelli C
Ann Surg Oncol; 2009 Nov; 16(11):3010-9. PubMed ID: 19641970
[TBL] [Abstract][Full Text] [Related]
7. Detection of isolated tumor cells in BM from breast-cancer patients: significance of anterior and posterior iliac crest aspirations and the number of mononuclear cells analyzed.
Wiedswang G; Borgen E; Karesen R; Naume B
Cytotherapy; 2003; 5(1):40-5. PubMed ID: 12745581
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow cytokeratin 19 mRNA level is an independent predictor of relapse-free survival in operable breast cancer patients.
Farmen RK; Nordgård O; Gilje B; Shammas FV; Kvaløy JT; Oltedal S; Heikkilä R
Breast Cancer Res Treat; 2008 Mar; 108(2):251-8. PubMed ID: 17492378
[TBL] [Abstract][Full Text] [Related]
9. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
[TBL] [Abstract][Full Text] [Related]
10. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
[TBL] [Abstract][Full Text] [Related]
11. Effect of zoledronate on persisting isolated tumour cells in patients with early breast cancer.
Rack B; Jückstock J; Genss EM; Schoberth A; Schindlbeck C; Strobl B; Heinrigs M; Rammel G; Zwingers T; Sommer H; Friese K; Janni W
Anticancer Res; 2010 May; 30(5):1807-13. PubMed ID: 20592383
[TBL] [Abstract][Full Text] [Related]
12. Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse.
Bidard FC; Vincent-Salomon A; Gomme S; Nos C; de Rycke Y; Thiery JP; Sigal-Zafrani B; Mignot L; Sastre-Garau X; Pierga JY;
Clin Cancer Res; 2008 Jun; 14(11):3306-11. PubMed ID: 18519757
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
[TBL] [Abstract][Full Text] [Related]
14. Time independence of the prognostic impact of tumor cell detection in the bone marrow of primary breast cancer patients.
Solomayer EF; Diel IJ; Salanti G; Hahn M; Gollan C; Schütz F; Bastert G
Clin Cancer Res; 2001 Dec; 7(12):4102-8. PubMed ID: 11751508
[TBL] [Abstract][Full Text] [Related]
15. Prognostic markers in node-negative breast cancer: a prospective study.
Kute TE; Russell GB; Zbieranski N; Long R; Johnston S; Williams H; Stackhouse C; Wilkins L; Evans I; Berry P; Rimmer K; Tucker E
Cytometry B Clin Cytom; 2004 May; 59(1):24-31. PubMed ID: 15108167
[TBL] [Abstract][Full Text] [Related]
16. Breast conserving surgery after primary chemotherapy in locally advanced breast cancer.
Asoglu O; Muslumanoglu M; Igci A; Ozmen V; Karanlik H; Ayalp K; Bozfakioglu Y; Kecer M; Parlak M
Acta Chir Belg; 2005 Feb; 105(1):62-8. PubMed ID: 15790205
[TBL] [Abstract][Full Text] [Related]
17. S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients.
Gazic B; Pizem J; Bracko M; Cufer T; Borstnar S; Pohar-Marinsek Z; Us-Krasovec M
Cytopathology; 2008 Oct; 19(5):294-302. PubMed ID: 18070112
[TBL] [Abstract][Full Text] [Related]
18. Detection of isolated tumor cells in bone marrow in early-stage breast carcinoma patients: comparison with preoperative clinical parameters and primary tumor characteristics.
Naume B; Borgen E; Kvalheim G; Kåresen R; Qvist H; Sauer T; Kumar T; Nesland JM
Clin Cancer Res; 2001 Dec; 7(12):4122-9. PubMed ID: 11751511
[TBL] [Abstract][Full Text] [Related]
19. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.
Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L
J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993
[TBL] [Abstract][Full Text] [Related]
20. Survival in patients with brain metastases from breast cancer: the importance of HER-2 status.
Eichler AF; Kuter I; Ryan P; Schapira L; Younger J; Henson JW
Cancer; 2008 Jun; 112(11):2359-67. PubMed ID: 18361426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]